KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Operating Leases (2022 - 2025)

Globus Medical's Operating Leases history spans 4 years, with the latest figure at $103.9 million for Q4 2025.

  • For Q4 2025, Operating Leases rose 24.32% year-over-year to $103.9 million; the TTM value through Dec 2025 reached $103.9 million, up 24.32%, while the annual FY2025 figure was $103.9 million, 24.32% up from the prior year.
  • Operating Leases reached $103.9 million in Q4 2025 per GMED's latest filing, down from $105.0 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $107.9 million in Q2 2025 to a low of $3.5 million in Q4 2022.
  • Average Operating Leases over 4 years is $85.5 million, with a median of $89.8 million recorded in 2024.
  • Peak YoY movement for Operating Leases: surged 2519.77% in 2023, then fell 13.56% in 2024.
  • A 4-year view of Operating Leases shows it stood at $3.5 million in 2022, then soared by 2519.77% to $91.0 million in 2023, then dropped by 8.18% to $83.6 million in 2024, then rose by 24.32% to $103.9 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Operating Leases are $103.9 million (Q4 2025), $105.0 million (Q3 2025), and $107.9 million (Q2 2025).